Exane Derivatives’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-15,442
| Closed | -$1.09M | – | 876 |
|
|
2022
Q1 | $1.09M | Buy |
15,442
+2,372
| +18% | +$160K | 0.31% | 82 |
|
|
2021
Q4 | $817K | Sell |
13,070
-786
| -6% | -$49.3K | 0.2% | 109 |
|
|
2021
Q3 | $855K | Buy |
13,856
+286
| +2% | +$17.2K | 0.21% | 104 |
|
|
2021
Q2 | $796K | Buy |
13,570
+520
| +4% | +$33K | 0.19% | 107 |
|
|
2021
Q1 | $793K | Sell |
13,050
-762
| -6% | -$42.1K | 0.24% | 95 |
|
|
2020
Q4 | $649K | Buy |
13,812
+11,084
| +406% | +$480K | 0.2% | 114 |
|
|
2020
Q3 | $101K | Sell |
2,728
-439
| -14% | -$16.7K | 0.03% | 296 |
|
|
2020
Q2 | $116K | Sell |
3,167
-959
| -23% | -$33.4K | 0.04% | 277 |
|
|
2020
Q1 | $126K | Hold |
4,126
| – | – | 0.04% | 251 |
|
|
2019
Q4 | $214K | Buy |
4,126
+50
| +1% | +$2.41K | 0.04% | 253 |
|
|
2019
Q3 | $192K | Hold |
4,076
| – | – | 0.04% | 261 |
|
|
2019
Q2 | $202K | Sell |
4,076
-1,180
| -22% | -$55.5K | 0.04% | 265 |
|
|
2019
Q1 | $224K | Sell |
5,256
-766
| -13% | -$33.9K | 0.05% | 210 |
|
|
2018
Q4 | $247K | Buy |
6,022
+3,900
| +184% | +$167K | 0.06% | 223 |
|
|
2018
Q3 | $99.2K | Buy |
2,122
+788
| +59% | +$36K | 0.02% | 320 |
|
|
2018
Q2 | $59.3K | Buy |
1,334
+155
| +13% | +$7.23K | 0.01% | 376 |
|
|
2018
Q1 | $54K | Sell |
1,179
-84
| -7% | -$4.08K | 0.01% | 347 |
|
|
2017
Q4 | $63.9K | Sell |
1,263
-421
| -25% | -$22.2K | 0.01% | 327 |
|
|
2017
Q3 | $87.5K | Sell |
1,684
-2,991
| -64% | -$146K | 0.02% | 277 |
|
|
2017
Q2 | $229K | Buy |
4,675
+4,673
| +233,650% | +$217K | 0.06% | 196 |
|
|
2017
Q1 | $106 | Hold |
2
| – | – | ﹤0.01% | 489 |
|
|
2016
Q4 | $108 | Hold |
2
| – | – | ﹤0.01% | 538 |
|
|
2016
Q3 | $89 | Sell |
2
-4,521
| -100% | -$170K | ﹤0.01% | 538 |
|
|
2016
Q2 | $161K | Buy |
+4,523
| New | +$176K | 0.03% | 214 |
|
Other funds holding MET
